Get access

Severe Dyshidrotic Eczema after Intravenous Immunoglobulin Therapy for Kawasaki Syndrome


Address correspondence to Toshiyuki Yamamoto, M.D., Department of Dermatology, Fukushima Medical University, Fukushima 960-1295, Japan, or e-mail:


Abstract:  Dyshidrotic eczema is one of the rare cutaneous adverse effects of intravenous immunoglobulin therapy, usually seen in adults. We herein report the first pediatric case of severe dyshidrotic eczema occurring after intravenous immunoglobulin therapy for Kawasaki syndrome.

Get access to the full text of this article